← Back
$GILD All transactions

GILEAD SCIENCES, INC.

A

$ Value

$0

Shares

5,455

Price

$0

Filed

Mar 12

Insider

Name

Burkhart Erin

Title

SVP, Controllership

CIK

0001927648

Roles

Officer

Transaction Details

Transaction Date

2026-03-10

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

5,455

Footnotes

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. | The stock options have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Filing Info

Accession No.

0001927648-26-000002

Form Type

4

Issuer CIK

0000882095

Burkhart Erin's History

Date Ticker Type Value
2026-03-10 GILD A
2026-03-10 GILD A $0
2025-09-22 GILD A
2025-05-20 BMRN $106K
2025-05-19 BMRN F $59K

Other Insiders at GILD (90d)

Insider Bought Sold Last
Dickinson Andrew D
Chief Financial Officer
$463K 2026-03-10
Dickinson Andrew D / Mercier Johanna
Chief Financial Officer
$856K 2026-04-15
O'Day Daniel Patrick
Chairman & CEO
$21.6M 2026-03-27
Berger Dietmar
Chief Medical Officer
2026-03-10
Mercier Johanna
Chief Comm & Corp Aff Officer
$4.3M 2026-03-10
Burkhart Erin
SVP, Controllership
2026-03-10
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
2026-03-10